Gian Domenico Giusti, Nicola Ramacciati, Domenico Cardamonte, Giovanni Bellizzi, Andrea Bruni
The suspected foodborne botulism outbreak reported in Southern Italy in August 2025 generated a marked increase in public interest, reflected by a sharp rise in Google Trends searches related to botulism. Although web-search data cannot replace epidemiological surveillance, they may help contextualize public awareness during emerging health events. This episode highlights the continuing importance of early clinical recognition of botulism, a rare but potentially life-threatening neuroparalytic disease. Clinicians should suspect botulism in patients presenting with acute bilateral cranial neuropathies, dysphagia, dysarthria, and descending symmetrical weakness, particularly when compatible food-exposure histories are reported. Misdiagnosis remains frequent and may delay treatment. Current evidence and international guidelines emphasize that the diagnosis is primarily clinical and that administration of heptavalent botulinum antitoxin should not be postponed while awaiting laboratory confirmation. Rapid recognition, timely supportive care, and prompt antitoxin access remain the key determinants of patient outcomes during botulism outbreaks.